September 1, 2015
Australian pharmacists could soon substitute a biosimilar infliximab for its reference product without prescribing physicians’ –or even patients’—knowledge.
August 28, 2015
The FDA has issued new guidance that proposes giving distinct non-proprietary names to biologics and biosimilars.
August 27, 2015
When Congress resumes session in September, it must also resume negotiations on a tense topic—raising co-pay limits for veterans and military families relying on Tricare health coverage.
August 25, 2015
Physicians who prescribe opioid analgesics for kids with severe pain will now have the benefit of FDA guidance on pediatric dosing and safety.
August 20, 2015
Rising costs have brought public debate on patient access to cancer medications to a head.
August 18, 2015
New data confirms what neonatal health care providers and preemie advocates feared – without access to preventative care against respiratory syncytial virus, pre-term infants are suffering severe cases of the deadly disease unnecessarily.
August 13, 2015
For many Americans with respiratory conditions, the struggle to breathe is now exacerbated by the struggle to pay out-of-pocket expenses for the medications that alleviate their symptoms.
August 11, 2015
Colombian regulators’ ill-defined “alternative approach” to approving biosimilar medicines has the country’s patients unsettled.
August 6, 2015
If you thought vaccines were just for babies, think again.
August 4, 2015
How can regulators effectively create distinguishable names for biosimilars?
